Biotech Stock News (AVXL) (BIIB) (LLY) (SPHS) (KBIO)

Anavex Life Sciences (NASDAQ:AVXL) On November 9, 2015 Anavex reported positive phase 2a results for the trial treating patients with Alzheimer’s. This trial tested two clinical endpoints. The first clinical endpoint was testing for safety as it is customary with all phase 2a trials. The second endpoint was looking for preliminary clinical efficacy. In terms … Read more

Biotech Stock News (BIIB) (LLY) (AVXL) (ITEK) (XOMA)

Biogen (NASDAQ:BIIB) On July 22, 2015 shares of Biogen fell about 4% after reporting mixed results for its Alzheimer’s drug known as aducanumab. This phase 1b trial was known as the “PRIME” trial and patients were randomized into two different dosing groups. One group of patients either took 1 mg, 3 mg , 6 mg … Read more

Biotech Stock News (BIIB) (ESPR) (FOLD)

Biogen Idec (NASDAQ:BIIB) Shares of Biogen soared as much as 10% on Friday March 20, 2015 after the company reported that it had achieved a positive outcome in an early phase 1b trial in patients with Alzheimer’s. Matter in fact many Wall Street analysts were expecting a weak efficacy outcome but Biogen’s drug BIIB037 went … Read more